State of New Jersey Common Pension Fund D Increases Stock Holdings in Integer Holdings Corporation $ITGR

Key Points

• State of New Jersey Common Pension Fund D boosted its stake in Integer by 59.9% in Q4 to 31,836 shares, valued at about $2.497 million.
• Analysts have a consensus rating of "Hold" with an average price target of $98.29, amid mixed actions including several price‑target increases and at least one downgrade.
• Integer's most recent quarter showed $1.20 EPS (missed estimates by $0.01) while revenue of $439.6 million beat expectations, and management set FY2026 guidance of 5.83–6.40 EPS.

State of New Jersey Common Pension Fund D increased its holdings in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 59.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,836 shares of the medical equipment provider's stock after buying an additional 11,925 shares during the quarter. State of New Jersey Common Pension Fund D owned 0.09% of Integer worth $2,497,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. William Blair Investment Management LLC purchased a new position in Integer during the 3rd quarter worth $28,459,000. Public Sector Pension Investment Board grew its stake in Integer by 14.9% during the 3rd quarter. Public Sector Pension Investment Board now owns 136,632 shares of the medical equipment provider's stock worth $14,118,000 after buying an additional 17,699 shares during the last quarter. Magnetar Financial LLC purchased a new position in Integer during the 3rd quarter worth $1,890,000. New York State Common Retirement Fund grew its stake in Integer by 12.0% during the 3rd quarter. New York State Common Retirement Fund now owns 267,613 shares of the medical equipment provider's stock worth $27,652,000 after buying an additional 28,650 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA purchased a new position in Integer during the 3rd quarter worth $41,938,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Truist Financial boosted their target price on Integer from $95.00 to $97.00 and gave the stock a "buy" rating in a research note on Friday, February 20th. Raymond James Financial reiterated an "outperform" rating and set a $101.00 price target on shares of Integer in a research note on Monday, February 23rd. Piper Sandler reiterated an "overweight" rating and set a $97.00 price target (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Wall Street Zen downgraded Integer from a "buy" rating to a "hold" rating in a research note on Sunday, January 25th. Finally, Citigroup dropped their price target on Integer from $92.00 to $89.00 and set a "neutral" rating on the stock in a research note on Friday, May 1st. Four research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $98.29.

Integer Stock Up 0.7%

Integer stock opened at $86.47 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. The business's 50-day simple moving average is $86.10 and its two-hundred day simple moving average is $81.22. The company has a market cap of $2.94 billion, a PE ratio of 21.56, a PEG ratio of 1.49 and a beta of 0.67. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $123.78.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). The company had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. The business's quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the firm earned $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Equities analysts anticipate that Integer Holdings Corporation will post 6.11 EPS for the current year.

Insider Activity

In other news, VP Tommy P. Thomas sold 825 shares of the business's stock in a transaction dated Friday, March 13th. The stock was sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the transaction, the vice president owned 4,381 shares of the company's stock, valued at $372,385. The trade was a 15.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.10% of the stock is currently owned by company insiders.

Integer Profile

Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.